Agneta Nordberg
Agneta Nordberg is an expert in Neurology at Karolinska Institute (Sweden). As of June 2026, ScienceLeadR ranks Agneta Nordberg in the top 1% of experts worldwide for Alzheimer Disease, Dementia and Neurocognitive Disorders. Agneta Nordberg has authored 594 publications, the most recent in 2026, and is an investigator in 2 clinical trials, 1 of them ongoing. SLR score: 2,028 (community average: 125). How the SLR is computed.
LeadR Profile
Neurology
Subspecialties: Biochemistry - Psychiatry - Nuclear Medicine
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 1992 - 2026
Number : 594
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| [ 18F]RO948 Tau PET in early and late onset Alzheimer's disease: associations with plasma p-tau 217, atrophy and cognition. PMID 42360329 — hippocampus, entorhinal cortex, atrophy, alzheimer disease, brain, amygdala, parietal lobe, cognition, plasma | Eur J Nucl Med Mol Imaging | 2026 | 0 |
| Author Correction: Curing the brain: in search for new astrocyte-specific therapies. PMID 42115334 — astrocytes, brain, therapeutics | Exp Mol Med | 2026 | 0 |
| Curing the brain: in search for new astrocyte-specific therapies. PMID 42032208 — astrocytes, brain, pathology, gliosis, therapeutics, wounds and injuries | Exp Mol Med | 2026 | 0 |
| Co-pathologies and biological processes beyond amyloid-beta and tau in people with Alzheimer's disease: Evidence from clinical cohort studies. PMID 41988825 — amyloid beta-peptides, alzheimer disease, internal medicine, pathology, cohort studies, synucleinopathies, signs and symptoms, amyloid, cholinergic agents | J Intern Med | 2026 | 0 |
| Integration over reduction: multimodal PET and fluid biomarkers in Alzheimer's disease and beyond. PMID 41725559 — alzheimer disease, pathology, biomarkers, sex, precision medicine, diagnosis, amyloid, neuropathology, nervous system diseases, plasma | Curr Opin Neurol | 2026 | 0 |
Clinical Studies 2
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Main Topics
Cohort/Consortium Investigators 2
Ongoing Clinical Trials
Ongoing trial started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| Molecular PET Imaging and Plasma Biomarkers in Alzheimer s Disease and Other Neurodegenerative Diseases NCT06731842 — alzheimer disease, positron-emission tomography, brain, biomarkers, neurodegenerative diseases, plasma | N/A | Enrolling by invitation | 2022 |
LeadR Networks
Main global connection map